CASI Pharmaceuticals
CASI
#9690
Rank
HK$0.29 B
Marketcap
HK$19.05
Share price
-1.21%
Change (1 day)
-56.11%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2022 (TTM): -HK$23.32

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$23.17. In 2021 the company made an earnings per share (EPS) of -HK$21.15 an increase over its 2020 EPS that were of -HK$33.98.

EPS history for CASI Pharmaceuticals from 1996 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$23.3210.28%
2021-HK$21.15-37.76%
2020-HK$33.98-8.96%
2019-HK$37.3250%
2018-HK$24.8877.78%
2017-HK$14.00-7.42%
2016-HK$15.12-11.63%
2015-HK$17.11-75.56%
2014-HK$69.98309.09%
2013-HK$17.11-72.84%
2012-HK$62.9868.75%
2011-HK$37.32-48.94%
2010-HK$73.09-19.66%
2009-HK$90.97-62.01%
2008-HK$239.49-0%
2007-HK$239.49-62.67%
2006-HK$641.49134.38%
2005-HK$273.70-13.51%
2004-HK$316.47-44.78%
2003-HK$573.06-62.36%
2002-HK$1,522-26.14%
2001-HK$2,061-20.72%
2000-HK$2,60013.43%
1999-HK$2,292150.47%
1998-HK$915.1994.55%
1997-HK$470.4327.91%
1996-HK$367.79